Lv41
670 积分 2023-07-24 加入
Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial
5分钟前
已完结
Treatment of moderate-to-severe psoriasis in adults: An expert consensus statement using a Delphi method to produce a decision-making algorithm
34分钟前
求助中
Efficacy and safety of piclidenoson in plaque psoriasis: Results from a randomized phase 3 clinical trial (COMFORT‐1)
56分钟前
已完结
Oral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and an acceptable safety profile in participants with moderate-to-severe plaque psoriasis in a phase 2b, randomized, double-blind, placebo-controlled study
1小时前
已完结
Apremilast with Add-On Calcipotriene/Betamethasone Dipropionate for Treating Moderate to Severe Plaque Psoriasis
1小时前
已完结
Effects of oral roflumilast therapy on body weight and cardiometabolic parameters in patients with psoriasis – results from a randomized controlled trial (PSORRO)
1小时前
已关闭
Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS)
2小时前
已完结
TYK2 as a novel therapeutic target in psoriasis
2小时前
已完结
Selective TYK2 inhibitors as potential therapeutic agents: a patent review (2019–2021)
2小时前
已完结
Current and emerging biologic and small molecule systemic treatment options for psoriasis and psoriatic arthritis
3小时前
已完结
皖公网安备34019202002308
